Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lynx

Explore full profile

Lynx FinHealth is an API-connected modern banking, payment, and digital health infrastructure that empowers healthcare companies to meet people where they are

Boston, United StatesFounded 2021Health Tech & Medtech
Valuation $100–250M Last recorded · 2025
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Lynx and the history behind them.

About Lynx

Founded in 2021, Lynx is a financial technology company operating at the intersection of healthcare and finance, with its headquarters in Boston, Massachusetts. The company was established by co-founders Matthew Renfro, the CEO, and Ken Abel, the CIO, who both brought extensive experience from senior executive roles at major healthcare and financial service organizations like Optum, UnitedHealthcare, and Fidelity Investments. Their collective background in both regulated industries shaped the company's mission to address the disconnect between how consumers manage their finances and their healthcare by building a modern, API-first platform.

Lynx provides an embedded finance platform designed for the healthcare industry. Its core business revolves around offering a suite of programmatic APIs and white-label solutions that allow enterprise clients—such as health plans, benefits administrators, digital health companies, and financial institutions—to integrate customizable financial services directly into their own user experiences. The business model operates similarly to a neobank, generating revenue through monthly fees on the payment cards and bank accounts it administers on behalf of its partners. By doing so, Lynx displaces legacy claims systems with a modern, unified infrastructure.

The company's technology enables a wide range of consumer-directed health (CDH) accounts, including Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Health Reimbursement Arrangements (HRAs), as well as supplemental benefits for Medicare Advantage and Individual Coverage HRAs (ICHRAs). A key feature of the platform is its ability to perform real-time, SKU-level adjudication for purchases, ensuring that funds are spent on eligible products and services at tens of thousands of retailers. This allows partners to issue physical or virtual payment cards with highly specific spending controls. Furthermore, the platform supports integrated e-commerce marketplaces and investment options for health savings, aiming to provide a seamless financial experience for the end-user. Since its inception, Lynx has raised over $44 million in funding from investors including Flare Capital Partners, CVS Health Ventures, and McKesson Ventures.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Boston, United States
Employees
216
Open positions
2
Dealroom signal
68.2/100
Industry
Health, Fintech
Sub-industry
Health Platform, Payments
Sector
Health Tech & Medtech
Business model
SaaS
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Feb 2025 $27M $108M CVS Health Ventures · Flare Capital Partners · Frist Cressey Ventures · .406 Ventures ↗
SERIES A✓Equity / VC Mar 2022 $15M $60M Winter Street Ventures · Huntington Avenue Ventures · Shields Health Innovations · Frist Cressey Ventures ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Lynx website traffic

Latest recorded traffic for Lynx is 3.2K monthly website visits, up 33.3% over the last three months. Lynx's team declined 0.5% over the past year.

Latest monthly visits3.2K 3-month web change+33.3% 1-year team growth-0.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Frist Cressey Ventures

Series A8 investors entered at this stage

  • .406 Ventures
  • Obvious Ventures
  • Winter Street Ventures
  • Huntington Avenue Ventures
  • Shields Health Innovations
  • Flare Capital Partners
  • CVS Health Ventures
  • McKesson Ventures
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States94.9%
🇪🇸 Spain2.6%
🇵🇭 Philippines2.6%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Lynx on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lynx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.